Coronary Artery Bypass With Multiarterial Grafting vs Percutaneous Coronary Intervention

被引:6
作者
Bianco, Valentino
Mulukutla, Suresh
Aranda-Michel, Edgar
Chu, Danny
Kaczorowski, David
Bonatti, Johannes
Yoon, Pyongsoo
Kliner, Dustin
Toma, Catalin
Wang, Yisi
Koscumb, Steve
Thoma, Floyd
Navid, Forozan
Serna-Gallegos, Derek
Sultan, Ibrahim [1 ]
机构
[1] Heart & Vasc Inst, Div Cardiac Surg, 5200 Ctr Ave,Ste 715, Pittsburgh, PA 15232 USA
关键词
DRUG-ELUTING STENTS; SURVIVAL; METAANALYSIS; DISEASE; REVASCULARIZATION; GUIDELINES; MORTALITY; OUTCOMES;
D O I
10.1016/j.athoracsur.2022.06.028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Data comparing patients who undergo multiarterial grafting during coronary artery bypass grafting (CABG) vs percutaneous coronary intervention (PCI) in patients with multivessel coronary disease are scarce. This study addresses the relevance of using multiple arterial conduits vs PCI for appropriate patients.METHODS This retrospective study included all patients with coronary artery disease who underwent CABG with multiple arterial conduits or PCI. Propensity score matching was performed for baseline characteristics. Kaplan-Meier estimates, cumulative incidence, and freedom from major adverse cardiac and cerebrovascular events (MACCE) curves were performed.RESULTS The total patient population consisted of 3648 patients from 2011 to 2018 divided into 902 CABG patients and 2746 PCI patients. Patients were propensity matched (PCI, n = 838; CABG, n = 838). In the CABG cohort the left internal mammary artery was used in 837 patients (99.9%), the right internal mammary artery in 770 patients (92%), and radial arteries in 108 patients (12.9%). Patients in the PCI cohort had significantly higher 30-day mortality (24 [2.9%] vs 7 [0.8%], P < .01). Survival over follow-up (median, 4.9 years; range, 3.3-6.8) was better for the CABG cohort (730 [87.1%] vs 625 [74.6%], P < .01). Patients in the CABG cohort had greater freedom from MACCE (607 [72.4%] vs 339 [40.5%], P < .01). Cox multivariable regression showed that patients who underwent CABG had a significantly reduced risk of mortality (hazard ratio, 0.49; 95% confidence interval, 0.39-0.61; P < .01) and of MACCE (hazard ratio, 0.33; 95% confidence interval, 0.28-0.38; P < .01).CONCLUSIONS Patients with coronary artery disease who undergo CABG with multiple arterial conduits have significantly fewer major adverse events, improved survival, and reduced hospital readmissions.(Ann Thorac Surg 2023;115:404-11)(c) 2023 by The Society of Thoracic Surgeons
引用
收藏
页码:404 / 410
页数:7
相关论文
共 22 条
[1]   Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention With First-Generation Drug-Eluting Stents [J].
Al Ali, Juwairia ;
Franck, Caroline ;
Filion, Kristian B. ;
Eisenberg, Mark J. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (05) :497-506
[2]   The Society of Thoracic Surgeons Clinical Practice Guidelines on Arterial Conduits for Coronary Artery Bypass Grafting [J].
Aldea, Gabriel S. ;
Bakaeen, Faisal G. ;
Pal, Jay ;
Fremes, Stephen ;
Head, Stuart J. ;
Sabik, Joseph ;
Rosengart, Todd ;
Kappetein, A. Pieter ;
Thourani, Vinod H. ;
Firestone, Scott ;
Mitchell, John D. .
ANNALS OF THORACIC SURGERY, 2016, 101 (02) :801-809
[3]   State of the art in coronary revascularization: Everolimus eluting stents versus multiple arterial grafting [J].
Benedetto, Umberto ;
Caputo, Massimo ;
Vohra, Hunaid ;
Bryan, Alan ;
Angelini, Gianni D. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 219 :345-349
[4]   Coronary surgery is superior to drug eluting stents inmultivessel disease. Systematic review and meta-analysis of contemporary randomized controlled trials [J].
Benedetto, Umberto ;
Gaudino, Mario ;
Ng, Colin ;
Biondi-Zoccai, Giuseppe ;
D'Ascenzo, Fabrizio ;
Frati, Giacomo ;
Girardi, Leonard N. ;
Angelini, Gianni D. ;
Taggart, David P. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 210 :19-24
[5]   Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention in Patients With Diabetes [J].
Bianco, Valentino ;
Kilic, Arman ;
Mulukutla, Suresh R. ;
Gleason, Thomas G. ;
Kliner, Dustin ;
Aranda-Michel, Edgar ;
Brown, James A. ;
Wang, Yisi ;
Allen, Christopher C. ;
Habertheuer, Andreas ;
Sultan, Ibrahim .
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2021, 33 (02) :368-377
[6]  
Bianco V, 2021, J THORAC CARDIOV SUR, V161, P1022, DOI 10.1016/j.jtcvs.2020.06.159
[7]   CABG Versus PCI Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting [J].
Habib, Robert H. ;
Dimitrova, Kamellia R. ;
Badour, Sanaa A. ;
Yammine, Maroun B. ;
El-Hage-Sleiman, Abdul-Karim M. ;
Hoffman, Darryl M. ;
Geller, Charles M. ;
Schwann, Thomas A. ;
Tranbaugh, Robert F. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (13) :1417-1427
[8]   Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data [J].
Head, Stuart J. ;
Milojevic, Milan ;
Daemen, Joost ;
Ahn, Jung-Min ;
Boersma, Eric ;
Christiansen, Evald H. ;
Domanski, Michael J. ;
Farkouh, Michael E. ;
Flather, Marcus ;
Fuster, Valentin ;
Hlatky, Mark A. ;
Holm, Niels R. ;
Hueb, Whady A. ;
Kamalesh, Masoor ;
Kim, Young-Hak ;
Makikallio, Timo ;
Mohr, Friedrich W. ;
Papageorgiou, Grigorios ;
Park, Seung-Jung ;
Rodriguez, Alfredo E. ;
Sabik, Joseph F., III ;
Stables, Rodney H. ;
Stone, Gregg W. ;
Serruys, Patrick W. ;
Kappetein, Arie Pieter .
LANCET, 2018, 391 (10124) :939-948
[9]   Drug-eluting stents versus bilateral internal thoracic grafting for multivessel coronary disease [J].
Herz, I ;
Moshkovitz, Y ;
Loberman, D ;
Uretzky, G ;
Braunstein, R ;
Hendler, A ;
Zivi, E ;
Ben-Gal, Y ;
Mohr, R .
ANNALS OF THORACIC SURGERY, 2005, 80 (06) :2086-2090
[10]   Left internal mammary artery usage in-coronary artery bypass grafting: a measure of quality control [J].
Karthik, S. ;
Fabri, B. M. .
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2006, 88 (04) :367-369